These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34462984)

  • 1. Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro.
    Fan S; Ge Y; Liu J; Liu H; Yan R; Gao T; Fan X; Xiao Z; An G
    J Clin Lab Anal; 2021 Oct; 35(10):e23986. PubMed ID: 34462984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
    Nakagawa S; Sakamoto Y; Okabe H; Hayashi H; Hashimoto D; Yokoyama N; Tokunaga R; Sakamoto K; Kuroki H; Mima K; Beppu T; Baba H
    Oncol Rep; 2014 Feb; 31(2):983-8. PubMed ID: 24337160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
    Zhu HQ; Ma JB; Song X; Gao HJ; Ma CQ; Chang H; Li HG; Liu FF; Lu J; Zhou X
    Oncol Rep; 2016 Dec; 36(6):3488-3496. PubMed ID: 27779693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma.
    Tang H; You T; Ge H; Gao J; Wang Y; Bai C; Sun Z; Han Q; Zhao RC
    Int Immunopharmacol; 2024 May; 133():112053. PubMed ID: 38615380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells.
    Zhou W; Chen X; He K; Xiao J; Duan X; Huang R; Xia Z; He J; Zhang J; Xiang G
    Oncol Rep; 2016 May; 35(5):2535-42. PubMed ID: 26935789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microwave Hyperthermia Combined with Gemcitabine Inhibits Proliferation 
and Induces Apoptosis of Human Lung Squamous Carcinoma Cells].
    Yang Y; Zhao Y; Ma S; Yang D
    Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):805-814. PubMed ID: 30454541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast Cancer.
    Chen S; Gao Y; Zhu P; Wang X; Zeng L; Jin Y; Zhi X; Yang H; Zhou P
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):125. PubMed ID: 35468684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report.
    Zhang A; Liu B; Xu D; Sun Y
    Medicine (Baltimore); 2019 Dec; 98(52):e18435. PubMed ID: 31876723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
    Luo Q; Zhang S; Zhang D; Feng R; Li N; Chen W; Chen X; Yang S
    Curr Pharm Biotechnol; 2021; 22(4):523-533. PubMed ID: 32576126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.
    Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Delgado JR; Perales S
    Pancreas; 2016 Feb; 45(2):269-80. PubMed ID: 26495790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutation.
    Lian Z; Du W; Zhang Y; Fu Y; Liu T; Wang A; Cai T; Zhu J; Zeng Y; Liu Z; Huang JA
    Thorac Cancer; 2020 Jul; 11(7):1934-1943. PubMed ID: 32433828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer.
    Zhang C; Cao H; Cui Y; Jin S; Gao W; Huang C; Guo R
    Thorac Cancer; 2021 Oct; 12(19):2574-2584. PubMed ID: 34510760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG; Yoon CY; Yu JH; Park MJ; Lee JE; Jeong SJ; Hong SK; Byun SS; Lee SE
    J Urol; 2011 Nov; 186(5):2084-93. PubMed ID: 21944112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells.
    Tang X; Zheng Y; Jiao D; Chen J; Liu X; Xiong S; Chen Q
    Anticancer Agents Med Chem; 2021; 21(6):747-755. PubMed ID: 32682383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
    Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
    PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
    Lin G; Lin KJ; Wang F; Chen TC; Yen TC; Yeh TS
    Dis Model Mech; 2018 May; 11(8):. PubMed ID: 29666220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
    Liu DL; Bu HQ; Jin HM; Zhao JF; Li Y; Huang H
    Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.